CDC

• Significant Changes to CDC Guidance or Materials
  • Updated: COVID Data Tracker is CDC’s home for COVID-19 data. It combines county, state, national, and global data from across the response in a series of interactive dashboards. Recent COVID Data Tracker releases and updates include:
    • The June 3,2022 COVID Data Tracker Weekly Review Interpretative Summary focuses on CDC’s updated booster guidance and booster uptake among children ages 5 through 11 years old.
    • On June 2, 2022, the Wastewater Surveillance tab was updated to display a national stacked bar chart showing how much virus levels have changed (increased and decreased) over time at wastewater sites across the United States. It shows the percent of total sites over time in each category of the percent change metric.
    • On June 2, 2022, a link to the ASPR COVID-19 Therapeutics website was added to the Additional COVID-related Data tab. This site provides current information on COVID-19 therapeutics thresholds, orders, and replenishment by jurisdiction.
    • On May 26, 2022, the Vaccination Trends tab was updated to display vaccination trends among people ages 50 years and older who received a second booster dose.
• New: CDC Rescinds Order Requiring Negative Pre-Departure COVID-19 Test Prior to Flight to the U.S. - the Order requiring persons to show a negative COVID-19 test result or documentation of recovery from COVID-19 before boarding a flight to the United States was rescinded effective on June 12, 2022 at 12:01AM ET. Airline passengers do not need to show documentation of a negative COVID-19 test result or documentation of recovery from COVID-19 prior to boarding a flight to the United States.
  • This change impacts multiple CDC pages including: Travel, International Travel during COVID-19, Non-U.S. citizen, Non-U.S. immigrants: Air Travel to the United States.

FDA 

• FDA Announces Tentative Advisory Committee Meeting Schedule Regarding COVID-19 Vaccines - On May 23, 2022, the Food and Drug Administration (FDA) revised the dates of the upcoming Vaccines and Related Biological Products Advisory Committee meetings due to new data from vaccine sponsors and expected submissions of emergency use authorization (EUA) requests. The new dates are as follows:
  • June 15, 2022 will be the new meeting date to discuss the Moderna COVID-19 vaccine EUA request for children 6 months through 5 years of age and Pfizer-BioNTech’s COVID-19 vaccine EUA request for children 6 months through 4 years of age, based on expected completion of an EUA submission.
  • Information on how to view the meetings can be found here: Vaccines and Related Biological Products Advisory Committee June 14-15, 2022 Meeting Announcement 
• On June 3, 2022, the FDA provided additional guidance to help prescribers evaluate potential drug-drug interactions when using Paxlovid for the treatment of COVID-19. Prescribers should review each patient’s complete medication list (including ALL prescription AND non-prescription medications such as vitamins, supplements, etc.) and use resources to evaluate for potential drug-drug interactions.  Current resources include the Paxlovid EUA Fact Sheet, the Paxlovid Patient Eligibility Screening Checklist Tool for Prescribers, and the University of Liverpool COVID-19 Drug Interactions Checker.

• McKesson Specialty (Moderna and Janssen) will not be delivering orders on July 5, 2022.
• Pfizer Centrally Distributed Vaccines
• • No vaccine deliveries will occur on Saturday, July 2 through Monday, July 4, 2022.
  • Pfizer will be closed for the holiday weekend, and no orders will be processed July 4-5, 2022.
  • Orders placed on Friday, July 1, 2022 will be delivered on Tuesday, July 5, 2022.
  • If you would like to hold delivery for Friday, July 1, 2022, contact Pfizer by Tuesday, June 28, 2022 at 9:00 p.m. EST via email at cvgovernment@pfizer.com.
  • If you would like to hold delivery for Tuesday, July 5, 2022, contact Pfizer by Wednesday, June 29, 2022 at 9:00 p.m. EST via email at cvgovernment@pfizer.com.
• Moderna and J&J/Janssen Centrally Distributed Vaccines
• • No vaccine deliveries will occur Saturday July 2 through Tuesday, July 5, 2022.
  • McKesson will be closed for the holiday weekend. No orders will be processed on July 4 or 5, 2022.
  • Orders placed by 12:00 p.m. EST on Friday, July 1, 2022 will be delivered on Wednesday, July 6, 2022.
  • McKesson Specialty customer service is reaching out to awardee and partner ordering points of contact to determine if order holds are requested. If you have not already spoken with McKesson Specialty customer service and want to request a hold for your orders for Friday, July 1, 2022, please call 1-833-343-2703 or email COVIDVaccineSupport@McKesson.com by 12:00 pm EST on Wednesday June 29, 2022.
• For questions about VaxMaX and its functionality, please visit the VaxMaX Help website, which includes reference guides and tutorial videos.

Check out our complete list of COVID-19 Vaccination Clinic Best Practices and our Lightning Learnings: Best Practices for Busy Providers!

• What Clinicians Need to Know About Available Therapeutic Options for COVID-19

• • Date: Thursday, June 16, 2022
  • Time: 2:00 PM – 3:00 PM ET
  • A few minutes before the webinar starts, please click on the Zoom link below to join: https://www.zoomgov.com/j/1603960029?pwd=Z0x1SE1mR3ZNUXFSK3hBckw3aFIyUT09
  • Passcode: 308026
  • Telephone: US: +1 669 254 5252
• Advisory Committee on Immunization Practices (ACIP) Meetings: Friday, June 17, 2022, 10 AM - 3:30 PM  and Saturday, June 18, 2022, 10 AM - 4 PM
  • Following the VRBPAC meeting, ACIP will discuss vaccination for children and recommendations on how the vaccines should be used.
  • Access these meetings here

Pfizer Webinars for Healthcare Providers

• Pfizer has expanded its training sessions to address questions about currently recommended COVID-19 vaccine products as well as vaccines for children that are anticipated to be approved through an EUA.
• The COVID-19 vaccine medical updates and site training webinars aim to educate providers and immunization staff on the proper use of the Pfizer-BioNTech COVID-19 vaccines.
• For details, see dates and links for upcoming training sessions.
  • The trainings will include presentations on COVID-19 vaccines with a MAROON Cap for individuals 6 months through 4 years of age.
  • Daily trainings (Monday through Friday) will begin Monday, June 20, 2022, and continue through July 8, 2022 (with no training on July 4th).
  • While current trainings follow a Tuesday, Wednesday, Thursday schedule, future trainings will be offered 5 days per week as the pediatric vaccines roll out (Please note, the COVID-19 vaccine has NOT yet been authorized or approved for use in individuals younger than 5 years of age)

AAP/ VDH Webinar

• In partnership with the Virginia Department of Health (VDH), the Virginia Chapter of the American Academy of Pediatrics (AAP) invites you to the upcoming webinar on June 20th from 12:15-1PM ET regarding the anticipated Pfizer and Moderna COVID-19 Vaccines for the 6-month to under 5-year population.
• During this webinar, we will hear about the COVID-19 vaccine efforts in Virginia to date, the impact of COVID-19 on the pediatric population, clinical information specific to the Pfizer and Moderna pediatric vaccines, and how to address vaccine hesitancy. We invite all pediatric providers to join us.
  • Webinar Information: 
    • Date: Monday, June 20, 2022
    • Time: 12:15PM – 1PM (ET)
    • Registration Link: Click here

VDH External Web Updates 

• External webpages are being updated to reflect the adjustments to quarantine recommendations released by VDH on June 10, 2022: Effective immediately, VDH will be revising its quarantine guidance for COVID-19. Specifically, for non-high risk situations, if a person is exposed to COVID-19, but has (1) tested positive for and recovered from COVID-19 within the last 6 months, or (2) is up to date on vaccines, or both, that person will no longer be recommended to quarantine, but rather should monitor for symptoms and follow isolation protocols should they appear. Note that this varies slightly from CDC guidance, which defines the post-infection immunity period as 90 days.
  • This change will apply to the general public, including but not limited to settings such as K-12 schools and early childhood education settings. Out of an abundance of caution, we will retain the 90-day standard for higher-risk situations, including healthcare workers, staff and residents of long-term care facilities, correctional facilities, and homeless shelters.
  • This change only pertains to quarantine recommendations for individuals and will not impact our case surveillance/case classification process for purposes of reporting probable or confirmed cases to CDC.
  • The recommendations for isolation with active disease or asymptomatic positive testing remain unchanged

• COVID-19 Vaccination Training Programs and Reference Materials for Healthcare Professionals
  • https://www.cdc.gov/vaccines/covid-19/downloads/COVID-19-Clinical-Training-and-Resources-for-HCPs.pdf

• Updated COVID-19 Vaccination FAQs
  • New questions were added to address the Novavax COVID-19 vaccine. Information was updated on the status of vaccines for children 6 months through 4 and 5 years of age and guidance for people vaccinated with COVID-19 vaccines not authorized in the United States. Information was consolidated in the Vaccination: Records section.

• Updated Health Professionals Page
  • Added links to two recent MMWR articles
  • Added resource link for Healthcare Provider FAQs